Press Releases

Date Title and Summary Additional Formats
Toggle Summary SCYNEXIS Receives Merial Research Collaboration Milestone Payment View HTML
Toggle Summary SCYNEXIS Announces Presentations of Data from Anti-fungal Drug Candidate at the 50th ICAAC Meeting View HTML
Toggle Summary SCYNEXIS Receives SHARP Award View HTML
Toggle Summary SCYNEXIS’ African Trypanosomiasis (Sleeping Sickness) Neglected Disease Discovery Research Published View HTML
Toggle Summary SCYNEXIS and Trevena Announce Strategic Collaboration to Enhance Discovery of Biased GPCR Ligands View HTML
Toggle Summary SCYNEXIS Presents In Vitro Toxicity Study Suggesting that SCY-635 is Unique in the Cyclophilin Inhibitor Class
Results presented in poster presentation at EASL
View HTML
Toggle Summary SCYNEXIS’ SCY-635 Demonstrates Impressive Barrier to Resistance in HCV Treatment
Candidate requires virus to develop multiple mutations to establish resistance Results presented in an oral presentation at EASL
View HTML
Toggle Summary SCYNEXIS Announces Acceptance of Abstracts Related to its Hepatitis C Clinical Candidate, SCY-635, for Presentation at 45th Annual Meeting of the European Association for the Study of the Liver View HTML
Toggle Summary SCYNEXIS to Present at the Canaccord Adams’ Hepatitis C Conference View HTML
Toggle Summary SCYNEXIS to Lead Discussion of Software System With Local Global Health Group View HTML